- Home
- BHVN vs UTG Comparison
BHVN vs UTG Comparison
Compare BHVN & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- UTG
- Stock Information
- Founded
- BHVN 2013
- UTG 2003
- Country
- BHVN United States
- UTG United States
- Employees
- BHVN N/A
- UTG N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- UTG Investment Managers
- Sector
- BHVN Health Care
- UTG Finance
- Exchange
- BHVN Nasdaq
- UTG Nasdaq
- Market Cap
- BHVN 1.9B
- UTG 2.8B
- IPO Year
- BHVN 2017
- UTG N/A
- Fundamental
- Price
- BHVN $20.25
- UTG $33.56
- Analyst Decision
- BHVN Strong Buy
- UTG
- Analyst Count
- BHVN 14
- UTG 0
- Target Price
- BHVN $62.92
- UTG N/A
- AVG Volume (30 Days)
- BHVN 2.2M
- UTG 317.8K
- Earning Date
- BHVN 05-16-2025
- UTG 01-01-0001
- Dividend Yield
- BHVN N/A
- UTG 7.28%
- EPS Growth
- BHVN N/A
- UTG N/A
- EPS
- BHVN N/A
- UTG 9.86
- Revenue
- BHVN N/A
- UTG $96,107,593.00
- Revenue This Year
- BHVN N/A
- UTG N/A
- Revenue Next Year
- BHVN $65.26
- UTG N/A
- P/E Ratio
- BHVN N/A
- UTG $3.20
- Revenue Growth
- BHVN N/A
- UTG 8.35
- 52 Week Low
- BHVN $15.79
- UTG $25.26
- 52 Week High
- BHVN $55.70
- UTG $35.29
- Technical
- Relative Strength Index (RSI)
- BHVN 43.84
- UTG 64.84
- Support Level
- BHVN $18.99
- UTG $32.86
- Resistance Level
- BHVN $24.06
- UTG $34.05
- Average True Range (ATR)
- BHVN 2.03
- UTG 0.53
- MACD
- BHVN 0.24
- UTG 0.24
- Stochastic Oscillator
- BHVN 42.62
- UTG 85.78
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.